Pathophysiology of Crohn's disease inflammation and recurrence

L Petagna, A Antonelli, C Ganini, V Bellato… - Biology direct, 2020 - Springer
Chron's Disease is a chronic inflammatory intestinal disease, first described at the beginning
of the last century. The disease is characterized by the alternation of periods of flares and …

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

S Singh, PS Dulai, A Zarrinpar… - Nature reviews …, 2017 - nature.com
Incidence of IBD is rising in parallel with overweight and obesity. Contrary to conventional
belief, about 15–40% of patients with IBD are obese, which might contribute to the …

Effect of lifestyle factors on outcomes in patients with inflammatory bowel diseases

JJ Rozich, A Holmer, S Singh - … journal of the American College of …, 2020 - journals.lww.com
Various lifestyle factors including physical activity and obesity, stress, sleep, and smoking
may modify the risk of developing inflammatory bowel diseases (IBDs). In patients with …

[HTML][HTML] European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, R Barazzoni, L Busetto… - Clinical Nutrition, 2022 - Elsevier
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

[HTML][HTML] Interaction of obesity and inflammatory bowel disease

JW Harper, TL Zisman - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of unknown etiology
that is thought to result from a combination of genetic, immunologic and environmental …

Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases

J Bilski, A Mazur-Bialy, D Wojcik, M Surmiak… - Biomolecules, 2019 - mdpi.com
Inflammatory bowel diseases (IBDs) are a group of disorders which include ulcerative colitis
and Crohn's disease. Obesity is becoming increasingly more common among patients with …

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint European Society for Clinical Nutrition and Metabolism/United European …

SC Bischoff, R Barazzoni, L Busetto… - United European …, 2022 - Wiley Online Library
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease

R Mao, G Doyon, IO Gordon, J Li, S Lin, J Wang… - Gut, 2022 - gut.bmj.com
Objective Creeping fat, the wrapping of mesenteric fat around the bowel wall, is a typical
feature of Crohn's disease, and is associated with stricture formation and bowel obstruction …

Practical guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, J Ockenga, A Eshraghian, R Barazzoni… - Clinical Nutrition, 2023 - Elsevier
Background Patients with chronic gastrointestinal disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

The mesentery in Crohn's disease: friend or foe?

JC Coffey, DP O'Leary, MG Kiernan… - Current opinion in …, 2016 - journals.lww.com
The mesentery in Crohn's disease: friend or foe? : Current Opinion in Gastroenterology The
mesentery in Crohn's disease: friend or foe? : Current Opinion in Gastroenterology Log in or …